.神经肌肉刺激对慢性阻塞性肺疾病急性加重期患者肺功能、
躯体症状及躯体活动能力的影响[J].现代生物医学进展英文版,2024,(24):4791-4793. |
神经肌肉刺激对慢性阻塞性肺疾病急性加重期患者肺功能、
躯体症状及躯体活动能力的影响 |
Effects of Neuromuscular Stimulation on Pulmonary Function, Somatic Symptoms and Physical Activity Ability in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
Received:August 09, 2024 Revised:September 01, 2024 |
DOI:doi: 10.13241/j.cnki.pmb.2024.24.048 |
中文关键词: 神经肌肉刺激 慢性阻塞性肺疾病 急性加重期 肺功能 躯体症状 躯体活动能力 |
英文关键词: Neuromuscular stimulation Chronic obstructive pulmonary disease Acute exacerbation Pulmonary function Somatic symptoms Physical activity ability |
基金项目:河北省卫健委医学科学研究课题(20210703);河北省医学科学研究课题计划项目(20211187) |
|
|
Hits: 4 |
Download times: 0 |
中文摘要: |
摘要 目的:探讨神经肌肉刺激对慢性阻塞性肺疾病急性加重期(AECOPD)患者肺功能、躯体症状及躯体活动能力的影响。方法:92例AECOPD患者分为对照组(呼吸训练干预,n=46)和试验组(对照组的基础上接受神经肌肉刺激干预,n=46)。观察两组肺功能指标[用力肺活量占预计值百分比(FVC% pred)、第1秒用力呼气容积(FEV1)/用力肺活量(FVC)]、躯体症状[改良版英国医学研究会呼吸困难量表(mMRC)、圣乔治呼吸问卷(SGRQ)]及躯体活动能力[6分钟步行实验(6MWT)、四肢骨骼肌质量指数(ASMI)]变化情况。结果:干预 8周后,两组FVC% pred、FEV1/FVC升高,且试验组高于对照组同期(P<0.05)。干预 8周后,两组SGRQ、mMRC评分下降,且试验组低于对照组同期(P<0.05)。干预 8周后,两组6MWT、ASMI升高,且试验组高于对照组同期(P<0.05)。结论:神经肌肉刺激用于AECOPD患者,可有效改善肺功能和躯体症状,提高躯体活动能力。 |
英文摘要: |
ABSTRACT Objective: To explore the effects of neuromuscular stimulation on pulmonary function, somatic symptoms and physical activity ability in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: 92 patients with AECOPD were divided into control group (respiratory training intervention, n=46) and experimental group (neuromuscular stimulation intervention on the basis of control group, n=46) by random number table method. The changes of pulmonary function indexes [forced vital capacity as a percentage of predicted value (FVC%pred), forced expiratory volume in the first second (FEV1)/forced vital capacity (FVC)], somatic symptoms [modified British medical research council dyspnea scale(mMRC), St. George's respiratory questionnaire (SGRQ)] and physical activity ability [6-minute walk test (6MWT), appendicular skeletal mass index (ASMI)] were observed in two groups. Results: 8 weeks after intervention, the FVC%pred and FEV1/FVC in two groups increased, with the experimental group being higher than the control group at the same time(P<0.05). 8 weeks after intervention, the scores of SGRQ and mMRC in two groups decreased, with the experimental group being lower than the control group at the same time(P<0.05). 8 weeks after intervention, the 6MWT and ASMI increased in two groups, with the experimental group being higher than the control group at the same time(P<0.05). Conclusion:Neuromuscular stimulation can effectively improve pulmonary function and somatic symptoms, and improve physical activity ability in patients with AECOPD. |
View Full Text
View/Add Comment Download reader |
Close |